GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans

Lærke Smidt Gasbjerg; Amalie Rasmussen Lanng; Bolette Hartmann; Alexander Hovard Sparre-Ulrich; Flemming Dela; Mikkel Christensen; Jens J Holst; Tina Vilsbøll; Mette Rosenkilde; Filip Krag Knop

GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans

Lærke Smidt Gasbjerg
, Amalie Rasmussen Lanng
, Bolette Hartmann
, Alexander Hovard Sparre-Ulrich
, Flemming Dela
, Mikkel Christensen
, Jens J Holst
, Tina Vilsbøll
, Mette Rosenkilde
, Filip Krag Knop

Originalsprog	Engelsk
Publikationsdato	14 sep. 2017
Antal sider	1
Status	Udgivet - 14 sep. 2017
Begivenhed	53rd Annual Meeting of the European Association for the study of Diabetes EASD - International Fair of Lisbon and MEO Arena, Rua do Bojador, Parque das Nações, Lisabon, Portugal Varighed: 11 sep. 2017 → 15 sep. 2017 https://www.easd.org/annual-meeting/easd-2017.html

Konference

Konference	53rd Annual Meeting of the European Association for the study of Diabetes EASD
Lokation	International Fair of Lisbon and MEO Arena, Rua do Bojador, Parque das Nações
Land/Område	Portugal
By	Lisabon
Periode	11/09/2017 → 15/09/2017
Internetadresse	https://www.easd.org/annual-meeting/easd-2017.html

Adgang til dokumentet

https://www.easd.org/virtualmeeting/home.html#!resources/gip-3-30-nh-sub-2-sub-is-an-efficacious-gip-receptor-antagonist-in-humans

Citationsformater

Gasbjerg, L. S., Lanng, A. R., Hartmann, B., Sparre-Ulrich, A. H., Dela, F., Christensen, M., Holst, J. J., Vilsbøll, T., Rosenkilde, M., & Knop, F. K. (2017). GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans. Abstract fra 53rd Annual Meeting of the European Association for the study of Diabetes EASD, Lisabon, Portugal. https://www.easd.org/virtualmeeting/home.html#!resources/gip-3-30-nh-sub-2-sub-is-an-efficacious-gip-receptor-antagonist-in-humans

Gasbjerg, LS, Lanng, AR, Hartmann, B, Sparre-Ulrich, AH, Dela, F , Christensen, M, Holst, JJ, Vilsbøll, T, Rosenkilde, M & Knop, FK 2017, 'GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans', 53rd Annual Meeting of the European Association for the study of Diabetes EASD, Lisabon, Portugal, 11/09/2017 - 15/09/2017. <https://www.easd.org/virtualmeeting/home.html#!resources/gip-3-30-nh-sub-2-sub-is-an-efficacious-gip-receptor-antagonist-in-humans>

@conference{402b84628dad4cb58d010ba1957f7721,

title = "GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans",

author = "Gasbjerg, \{L{\ae}rke Smidt\} and Lanng, \{Amalie Rasmussen\} and Bolette Hartmann and Sparre-Ulrich, \{Alexander Hovard\} and Flemming Dela and Mikkel Christensen and Holst, \{Jens J\} and Tina Vilsb{\o}ll and Mette Rosenkilde and Knop, \{Filip Krag\}",

year = "2017",

month = sep,

day = "14",

language = "English",

note = "53rd Annual Meeting of the European Association for the study of Diabetes EASD, EASD 2017 ; Conference date: 11-09-2017 Through 15-09-2017",

url = "https://www.easd.org/annual-meeting/easd-2017.html",

}

TY - ABST

T1 - GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans

AU - Gasbjerg, Lærke Smidt

AU - Lanng, Amalie Rasmussen

AU - Hartmann, Bolette

AU - Sparre-Ulrich, Alexander Hovard

AU - Dela, Flemming

AU - Christensen, Mikkel

AU - Holst, Jens J

AU - Vilsbøll, Tina

AU - Rosenkilde, Mette

AU - Knop, Filip Krag

PY - 2017/9/14

Y1 - 2017/9/14

M3 - Conference abstract for conference

T2 - 53rd Annual Meeting of the European Association for the study of Diabetes EASD

Y2 - 11 September 2017 through 15 September 2017

ER -